163 related articles for article (PubMed ID: 3155797)
1. Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1985 Feb; 232(2):492-500. PubMed ID: 3155797
[TBL] [Abstract][Full Text] [Related]
2. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
3. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
[TBL] [Abstract][Full Text] [Related]
4. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
Hoffmann IS; Talmaciu RK; Cubeddu LX
J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
[TBL] [Abstract][Full Text] [Related]
5. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
Hoffmann IS; Talmaciu RK; Ferro CP; Cubeddu LX
J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate.
Kamal LA; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Nov; 227(2):446-58. PubMed ID: 6631724
[TBL] [Abstract][Full Text] [Related]
7. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
Nowak JZ; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
[TBL] [Abstract][Full Text] [Related]
8. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
Dwoskin LP; Zahniser NR
J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803
[TBL] [Abstract][Full Text] [Related]
9. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
[TBL] [Abstract][Full Text] [Related]
10. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
Snyder GL; Keller RW; Zigmond MJ
J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
[TBL] [Abstract][Full Text] [Related]
11. Effects of amiloride and 5-(N,N-hexamethylene)amiloride on dopaminergic and cholinergic neurotransmission.
Zubieta JK; Cragoe EJ; Cubeddu LX
J Pharmacol Exp Ther; 1988 Oct; 247(1):88-95. PubMed ID: 2845061
[TBL] [Abstract][Full Text] [Related]
12. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
Suarez-Roca H; Lovenberg T; Cubeddu LX
J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
[TBL] [Abstract][Full Text] [Related]
13. Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro.
Zumstein A; Karduck W; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1981 Jun; 316(3):205-17. PubMed ID: 7254365
[TBL] [Abstract][Full Text] [Related]
14. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.
Jackisch R; Huang HY; Reimann W; Limberger N
J Pharmacol Exp Ther; 1993 Feb; 264(2):889-98. PubMed ID: 8094757
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
Misu Y; Goshima Y; Ueda H; Kubo T
J Pharmacol Exp Ther; 1985 Dec; 235(3):771-7. PubMed ID: 3001276
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
[TBL] [Abstract][Full Text] [Related]
17. Phorbol esters and D2-dopamine receptors.
Cubeddu LX; Lovenberg TW; Hoffman IS; Talmaciu RK
J Pharmacol Exp Ther; 1989 Nov; 251(2):687-93. PubMed ID: 2530340
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by 5,6-dihydroxy-2-dimethylaminotetralin (M7) of noradrenergic neurotransmission in the rabbit hypothalamus: role of alpha-2 adrenoceptors and of dopamine receptors.
Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1985 May; 233(2):459-65. PubMed ID: 2987485
[TBL] [Abstract][Full Text] [Related]
19. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
Chen NH; Reith ME
J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
[TBL] [Abstract][Full Text] [Related]
20. Alpha-2 adrenoceptors modulate [3H]dopamine release from rabbit retina.
Dubocovich ML
J Pharmacol Exp Ther; 1984 Jul; 230(1):149-55. PubMed ID: 6086874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
